http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020063727-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a4141a48ff4b100515aaad9e7844563 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate | 2019-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e92ddf569d38bef9dfe6247ad7373321 |
| publicationDate | 2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020063727-A1 |
| titleOfInvention | Tricyclic ring ask1 inhibitors and use thereof |
| abstract | The present invention relates to a compound as shown in general formula (I), and a pharmaceutically acceptable salt, ester or stereisomer thereof. The present invention also relates to a method for preparing the compound, a pharmaceutic preparation and a pharmaceutical composition comprising the compound. The compound of the present invention can effectively inhibit the amino acid of ASK1 from being phosphorylized, and can inhibit the activation of ASK1. Therefore, the compound can treat and/or prevent diseases mediated by ASK1 and related diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021031071-A1 |
| priorityDate | 2018-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.